Prospective study evaluating immune‐mediated mechanisms and predisposing factors underlying persistent postinfectious abdominal complaints

The role of persistent immune activation in postinfectious irritable bowel syndrome (PI‐IBS) remains controversial. Here, we prospectively studied healthy subjects traveling to destinations with a high‐risk to develop infectious gastroenteritis (IGE) in order to identify immune‐mediated mechanisms and risk factors of PI‐IBS.

[1]  B. Connor,et al.  Use of a multiplex DNA extraction PCR in the identification of pathogens in travelers’ diarrhea , 2018, Journal of travel medicine.

[2]  M. Riddle,et al.  Travelers' Diarrhea: An Update on the Incidence, Etiology, and Risk in Military Deployments and Similar Travel Populations. , 2017, Military medicine.

[3]  M. Camilleri,et al.  Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis. , 2017, Gastroenterology.

[4]  A. Nikpoor,et al.  Serum immune biomarkers in irritable bowel syndrome. , 2016, Clinics and research in hepatology and gastroenterology.

[5]  G. Boeckxstaens,et al.  Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis , 2015, Gut.

[6]  P. Enck,et al.  Systematic review with meta‐analysis: post‐infectious irritable bowel syndrome after travellers' diarrhoea , 2015, Alimentary pharmacology & therapeutics.

[7]  A. Ganesan,et al.  Epidemiology and self-treatment of travelers' diarrhea in a large, prospective cohort of department of defense beneficiaries. , 2015, Journal of travel medicine.

[8]  E. Wine,et al.  An update on travelers’ diarrhea , 2015, Current opinion in gastroenterology.

[9]  H. Dupont,et al.  Persistent abdominal symptoms in US adults after short-term stay in Mexico. , 2014, Journal of travel medicine.

[10]  H. Nielsen,et al.  Psychometric scores and persistence of irritable bowel after Campylobacter concisus infection , 2014, Scandinavian journal of gastroenterology.

[11]  A. Masclee,et al.  Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[12]  G. Rogler,et al.  Irritable bowel syndrome among a cohort of European travelers to resource-limited destinations. , 2011, Journal of travel medicine.

[13]  C. Mason,et al.  Travelers' diarrhea in Nepal: an update on the pathogens and antibiotic resistance. , 2011, Journal of travel medicine.

[14]  M. Mutsch,et al.  Diarrhoea in a large prospective cohort of European travellers to resource-limited destinations , 2010, BMC infectious diseases.

[15]  A. Garg,et al.  Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery , 2010, Gut.

[16]  K. Garsed,et al.  Postinfectious irritable bowel syndrome. , 2009, Gastroenterology.

[17]  J. Lloreta,et al.  Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: Results 3 years after gastroenteritis , 2009, Scandinavian journal of gastroenterology.

[18]  J. Kim,et al.  The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors , 2008, Journal of gastroenterology and hepatology.

[19]  Hinrich W. H. Göhlmann,et al.  Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[20]  R Jones,et al.  Guidelines on the irritable bowel syndrome: mechanisms and practical management , 2007, Gut.

[21]  J. Panés,et al.  Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[22]  R. Moss‐Morris,et al.  The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis , 2007, Gut.

[23]  A. Lavy,et al.  Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  K. Wannemuehler,et al.  On the Use of Zero-Inflated and Hurdle Models for Modeling Vaccine Adverse Event Count Data , 2006, Journal of biopharmaceutical statistics.

[25]  A. Garg,et al.  GASTROENTEROLOGY 2006;131:445–450 Incidence and Epidemiology of Irritable Bowel Syndrome After a Large Waterborne Outbreak of Bacterial Dysentery , 2022 .

[26]  T. Jelínek,et al.  Risk and spectrum of diseases in travelers to popular tourist destinations. , 2006, Journal of travel medicine.

[27]  B. Connor.  Sequelae of traveler's diarrhea: focus on postinfectious irritable bowel syndrome. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  H. Dupont,et al.  Epidemiology of travelers' diarrhea: details of a global survey. , 2006, Journal of travel medicine.

[29]  H. Dupont,et al.  Post-Diarrhea Chronic Intestinal Symptoms and Irritable Bowel Syndrome in North American Travelers to Mexico , 2004, The American Journal of Gastroenterology.

[30]  Wang Lh,et al.  Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis , 2004 .

[31]  X-C Fang,et al.  Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis , 2004, Gut.

[32]  M. Crowell,et al.  Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. , 2004, Gastroenterology.

[33]  R. Spiller,et al.  Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. , 2003, Gastroenterology.

[34]  N. Read,et al.  Increased rectal mucosal expression of interleukin 1β in recently acquired post-infectious irritable bowel syndrome , 2003, Gut.

[35]  B. Lowe,et al.  Risk and aetiology of diarrhoea at various tourist destinations , 2000, The Lancet.

[36]  D. Fuchs,et al.  The role of psychological and biological factors in postinfective gut dysfunction , 2000, Gut.

[37]  N. Read,et al.  The role of psychological and biological factors in postinfective gut dysfunction , 1999, Gut.

[38]  R. Spiller,et al.  Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients , 1997, BMJ.

[39]  N. Read,et al.  Psychometric scores and persistence of irritable bowel after infectious diarrhoea , 1996, The Lancet.

[40]  R. Black.  Epidemiology of travelers' diarrhea and relative importance of various pathogens. , 1990, Reviews of infectious diseases.